188 related articles for article (PubMed ID: 28298153)
1. Exploring Drug Dosing Regimens In Vitro Using Real-Time 3D Spheroid Tumor Growth Assays.
Lal-Nag M; McGee L; Titus SA; Brimacombe K; Michael S; Sittampalam G; Ferrer M
SLAS Discov; 2017 Jun; 22(5):537-546. PubMed ID: 28298153
[TBL] [Abstract][Full Text] [Related]
2. Real-time viability and apoptosis kinetic detection method of 3D multicellular tumor spheroids using the Celigo Image Cytometer.
Kessel S; Cribbes S; Bonasu S; Rice W; Qiu J; Chan LL
Cytometry A; 2017 Sep; 91(9):883-892. PubMed ID: 28618188
[TBL] [Abstract][Full Text] [Related]
3. A Novel Multiparametric Drug-Scoring Method for High-Throughput Screening of 3D Multicellular Tumor Spheroids Using the Celigo Image Cytometer.
Cribbes S; Kessel S; McMenemy S; Qiu J; Chan LL
SLAS Discov; 2017 Jun; 22(5):547-557. PubMed ID: 28346096
[TBL] [Abstract][Full Text] [Related]
4. Generation of Multicellular Tumor Spheroids with Microwell-Based Agarose Scaffolds for Drug Testing.
Gong X; Lin C; Cheng J; Su J; Zhao H; Liu T; Wen X; Zhao P
PLoS One; 2015; 10(6):e0130348. PubMed ID: 26090664
[TBL] [Abstract][Full Text] [Related]
5. RNAi High-Throughput Screening of Single- and Multi-Cell-Type Tumor Spheroids: A Comprehensive Analysis in Two and Three Dimensions.
Fu J; Fernandez D; Ferrer M; Titus SA; Buehler E; Lal-Nag MA
SLAS Discov; 2017 Jun; 22(5):525-536. PubMed ID: 28277887
[TBL] [Abstract][Full Text] [Related]
6. Establishment and Analysis of a 3D Co-Culture Spheroid Model of Pancreatic Adenocarcinoma for Application in Drug Discovery.
Meier-Hubberten JC; Sanderson MP
Methods Mol Biol; 2019; 1953():163-179. PubMed ID: 30912022
[TBL] [Abstract][Full Text] [Related]
7. Real-Time Apoptosis and Viability High-Throughput Screening of 3D Multicellular Tumor Spheroids Using the Celigo Image Cytometer.
Kessel S; Cribbes S; Bonasu S; Qiu J; Chan LL
SLAS Discov; 2018 Feb; 23(2):202-210. PubMed ID: 28915356
[TBL] [Abstract][Full Text] [Related]
8. The Generation of Three-Dimensional Head and Neck Cancer Models for Drug Discovery in 384-Well Ultra-Low Attachment Microplates.
Close DA; Camarco DP; Shan F; Kochanek SJ; Johnston PA
Methods Mol Biol; 2018; 1683():355-369. PubMed ID: 29082502
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional lung tumor microenvironment modulates therapeutic compound responsiveness in vitro--implication for drug development.
Ekert JE; Johnson K; Strake B; Pardinas J; Jarantow S; Perkinson R; Colter DC
PLoS One; 2014; 9(3):e92248. PubMed ID: 24638075
[TBL] [Abstract][Full Text] [Related]
10. A 3D Heterotypic Multicellular Tumor Spheroid Assay Platform to Discriminate Drug Effects on Stroma versus Cancer Cells.
Weydert Z; Lal-Nag M; Mathews-Greiner L; Thiel C; Cordes H; Küpfer L; Guye P; Kelm JM; Ferrer M
SLAS Discov; 2020 Mar; 25(3):265-276. PubMed ID: 31658853
[TBL] [Abstract][Full Text] [Related]
11. Loss of cancer drug activity in colon cancer HCT-116 cells during spheroid formation in a new 3-D spheroid cell culture system.
Karlsson H; Fryknäs M; Larsson R; Nygren P
Exp Cell Res; 2012 Aug; 318(13):1577-85. PubMed ID: 22487097
[TBL] [Abstract][Full Text] [Related]
12. High-throughput screening with nanoimprinting 3D culture for efficient drug development by mimicking the tumor environment.
Yoshii Y; Furukawa T; Waki A; Okuyama H; Inoue M; Itoh M; Zhang MR; Wakizaka H; Sogawa C; Kiyono Y; Yoshii H; Fujibayashi Y; Saga T
Biomaterials; 2015 May; 51():278-289. PubMed ID: 25771018
[TBL] [Abstract][Full Text] [Related]
13. A 1536-Well 3D Viability Assay to Assess the Cytotoxic Effect of Drugs on Spheroids.
Madoux F; Tanner A; Vessels M; Willetts L; Hou S; Scampavia L; Spicer TP
SLAS Discov; 2017 Jun; 22(5):516-524. PubMed ID: 28346088
[TBL] [Abstract][Full Text] [Related]
14. Reproducibility of Uniform Spheroid Formation in 384-Well Plates: The Effect of Medium Evaporation.
Das V; Fürst T; Gurská S; Džubák P; Hajdúch M
J Biomol Screen; 2016 Oct; 21(9):923-30. PubMed ID: 27226477
[TBL] [Abstract][Full Text] [Related]
15. Large-Scale Gene Expression Profiling Platform for Identification of Context-Dependent Drug Responses in Multicellular Tumor Spheroids.
Senkowski W; Jarvius M; Rubin J; Lengqvist J; Gustafsson MG; Nygren P; Kultima K; Larsson R; Fryknäs M
Cell Chem Biol; 2016 Nov; 23(11):1428-1438. PubMed ID: 27984028
[TBL] [Abstract][Full Text] [Related]
16. The Influence of Antitumor Unsymmetrical Bisacridines on 3D Cancer Spheroids Growth and Viability.
Kulesza J; Pawłowska M; Augustin E
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684841
[TBL] [Abstract][Full Text] [Related]
17. High-throughput CRISPR-mediated 3D enrichment platform for functional interrogation of chemotherapeutic resistance.
Grandhi TSP; To J; Romero A; Luna F; Barnes W; Walker J; Moran R; Newlin R; Miraglia L; Orth AP; Horman SR
Biotechnol Bioeng; 2021 Aug; 118(8):3187-3199. PubMed ID: 34050941
[TBL] [Abstract][Full Text] [Related]
18. Development of an in vitro tumor spheroid culture model amenable to high-throughput testing of potential anticancer nanotherapeutics.
Solomon MA; Lemera J; D'Souza GG
J Liposome Res; 2016 Sep; 26(3):246-60. PubMed ID: 26780923
[TBL] [Abstract][Full Text] [Related]
19. A polymer microstructure array for the formation, culturing, and high throughput drug screening of breast cancer spheroids.
Markovitz-Bishitz Y; Tauber Y; Afrimzon E; Zurgil N; Sobolev M; Shafran Y; Deutsch A; Howitz S; Deutsch M
Biomaterials; 2010 Nov; 31(32):8436-44. PubMed ID: 20692698
[TBL] [Abstract][Full Text] [Related]
20. Microfluidic assembly of hydrogel-based immunogenic tumor spheroids for evaluation of anticancer therapies and biomarker release.
Sabhachandani P; Sarkar S; Mckenney S; Ravi D; Evens AM; Konry T
J Control Release; 2019 Feb; 295():21-30. PubMed ID: 30550941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
